Patent Grant
9517301
This document relates to an infusion pump system, such as a medical infusion pump system.
Pump devices are commonly used to deliver one or more fluids to a targeted individual. For example, a medical infusion pump device may be used to deliver a medicine to a patient as part of a medical treatment. The medicine that is delivered by the infusion pump device can depend on the condition of the patient and the desired treatment plan. For example, infusion pump devices have been used to deliver insulin to the vasculature of diabetes patients so as to regulate blood-glucose levels.
A number of factors may affect the design of infusion pump devices. One such factor is the size of the device. The pump device may be sized to house the various pump components, yet a large device may reduce the portability for the user. Another factor that may affect the design of an infusion pump device is the convenience to the user. For example, if the pump device is designed to be controlled via a user interface on a large wireless module that must be separately carried, the user may not be able to monitor the operation of the infusion pump during use without first locating, handling, and interfacing with the separate wireless module. A number of infusion pump components can impact the overall size and portability of an infusion pump system and the convenience to the user.
Some embodiments of a medical infusion pump system include a pump device and a removable controller device. When the pump device and the removable controller device are removably attached to one another, the components may provide a portable infusion pump unit to dispense medicine to a user. In particular embodiments, the removable controller device includes a user interface to readily provide information, for example, about the operation of the pump.
In some embodiments, a medical infusion pump system may include a pump device having a drive system to dispense a medicine from the pump device. At least a portion of the drive system may be in electrical communication with one or more electrical contacts of the pump device. The system may also include a removable controller device having a user interface. The removable controller device may be removably attachable to the pump device in a fixed relationship. The controller device may include one or more electrical contacts that engage the electrical contacts of the pump device when removably attached.
Particular embodiments of a medical infusion pump system may include a pump device having a drive system to dispense a medicine from the pump device. The system may also include a first removable controller device having a first user interface. The first removable controller device may be mechanically attachable to the pump device and may be electrically connected to the pump device when mechanically attached. The system may further include a second removable controller device having a second user interface that is different from the first user interface. The second removable controller device may be mechanically attachable to the pump device and may electrically connected to the pump device when mechanically attached. In certain aspects, the pump device may be mechanically attachable to only one of the first and second removable controller devices at a time.
Some embodiments of a medical infusion pump system may include a pump device having a drive system to dispense a medicine from the pump device. The pump device may include a first battery. The system may also include a removable controller device mechanically attachable to the pump device. The removable controller device may be electrically connected to the pump device when mechanically attached. The controller device may include a second battery. The first battery may have a greater energy density than the second battery and may provide energy to charge the second battery over a period of time. The second battery may provide energy to at least a portion of the drive system of the pump device.
In certain embodiments, a medical infusion pump system includes a pump device and a removable controller device. The pump device may include a pump housing that defines a space to receive a medicine and a drive system to dispense the medicine when received by the pump housing. The drive system may include a piston rod that is incrementally movable to apply a dispensing force. The pump device may also include one or more electrical contacts disposed on the pump housing. At least a portion of the drive system may be in electrical communication with the one or more of the electrical contacts. The removable controller device may include a controller housing that is removably attachable to the pump housing in a fixed relationship. The removable controller device may also include one or more electrical contacts disposed on the controller housing. The electrical contacts of the controller device may be engageable with the electrical contacts of the pump device when removably attached. The removable controller device may further include a user interface arranged on the controller housing. The user interface may include a display and one or more user-selectable buttons. The pump device and the controller device, when removably attached, may provide a hand-graspable portable unit.
Some embodiments described herein may include a method for operating a medical infusion pump system. The method may include transmitting electrical energy, from a first battery in a pump device to a second battery in a removable controller device. The pump device may include a drive system to dispense a medicine from the pump device, and the removable controller device may be removably attached to and electrically connected to the pump device. The method may also include intermittently transmitting electrical energy from the second battery in the removable controller device to at least a portion of the drive system of the pump device. The first battery may have a greater energy density than the second battery and may provide energy to charge the second battery over a period of time.
These and other embodiments may provide one or more of the following advantages. First, the infusion pump system may be portable so that a user can wear the pump device (e.g., adhered to the user's skin or carried in a user's pocket or portion of clothing) and receive the infused medicine throughout the day or night. Second, the pump device of the infusion pump system may include a drive system that controllably dispenses medicine in a reliable manner. Third, the pump device of the infusion pump system can be removably attached to a controller device having a user interface. As such, the user can readily monitor the operation of the pump device without the need for carrying and operating an separate wireless module. Fourth, the infusion pump system may comprise two or more removable controller devices having different user interfaces. In these circumstances, a first controller device having a first user interface can be selected for use with the pump device, or a second controller device having a second user interface can be selected for use with the pump device. Fifth, the pump device may be capable of dispensing a first medicine when connected with a first controller device and may be capable of dispensing a second medicine when connected with a second controller device. Sixth, the pump device may include a first battery that recharges a second battery in the controller device, which in turn provides power to the drive system of the pump. Thus, each time a new pump device is connected to the controller device, the second battery in the reusable controller device is recharged, thereby reducing or possibly eliminating the need for separate recharging of the controller device.
The details of one or more embodiments of the invention are set forth in the accompanying drawings and the description below. Other features, objects, and advantages of the invention will be apparent from the description and drawings, and from the claims.
Like reference symbols in the various drawings indicate like elements.
Referring to
In some embodiments, the controller device 200 may be removably attached to pump device 100 so that the two components are mechanically mounted to one another in a fixed relationship. Such a mechanical mounting can releasably secure an electrical connection between the removable controller device 200 and the pump device 100. For example, the controller device 200 may be in electrical communication with a portion of a drive system (not shown in
Still referring to
As described in more detail below in connection with
Still referring to
As shown in
Accordingly, when the controller device 200 is connected to the pump device 100, the user is provided with the opportunity to readily monitor infusion pump operation by simply viewing the user interface 220 connected to the pump device 100. Such monitoring capabilities may provide comfort to a user who may have urgent questions about the current operation of the pump device 100 (e.g., the user may be unable to receive immediate answers if wearing an infusion pump device having no user interface attached thereto).
Also, there is no need for the user to carry and operate a separate module to monitor the operation of the infusion pump device 100, thereby simplifying the monitoring process and reducing the number of devices that must be carried by the user. If a need arises in which the user desires to monitor the operation of the pump device 100 or to adjust settings of the pump system 10 (e.g., to request a bolus amount of medicine), the user can readily operate the user interface 220 removably attached to the pump device 100, without the requirement of locating and operating a separate monitoring module.
It should be understood from the description herein that the user interface 200 is not limited to the display and buttons depicted in
Referring to
As shown in
In other embodiments, the infusion pump system 10 may be configured to adhere to the user's skin directly at the location in which the skin is penetrated for medicine infusion. For example, a rear surface 102 of the pump device 100 (refer, for example, to
Referring to
The pump device 100 can be releasably secured to any one of the controller devices 200 and 300 in the infusion pump system 20. As previously described, the pump device 100 includes a pump housing structure 110, and at least a portion of the pump housing structure 110 is configured to be received in a complementary cavity 215 or 315 (
In some embodiments of the infusion pump system 20, the first and second controller devices 200 and 300 may be configured to control the dispensation of the same type of medicine when the pump device 100 is removably attached thereto. For example, a medicine cartridge containing insulin may be received in the pump device 100, and the user may select (e.g., based upon the user's preference, based upon an expert's recommendation, or a combination thereof) either the first controller device 200 or the second controller device 300 for attachment to the pump device 100. Because the first controller device 200 includes a user interface 220 that is different from the user interface 320 of the second controller device 300, the user may prefer the operation, appearance, or functionality of one controller device (200 or 300) over the other (300 or 200). For example, some users may select the first controller device 200 to provide a simplified input comprising two buttons 224a and 224b in the user interface 220 (e.g., lower complexity of input options may be preferable to child users). In another example, some users may select the second controller device 300 to provide a larger size display 322 and increased button options 324a, 324b, 324c, and 324d in the user interface 320 (e.g., increased input options may be preferably to users who frequently monitor a number of pump settings and summary screens). Alternatively, the controller devices 200 and 300 may include the same user interface option, but may have different appearances so as to provide the user with a variety of styles. For example, the controller device 200 may have a different outer shape or a different color than that of the second controller device 300, thereby permitting the user to select one of the controller devices 200 or 300 depending upon the desired appearance of the infusion pump system 20.
Still referring to
Such embodiments of the infusion pump device 20 permit a user to transition from the infusion of one type of medicine to a second type of medicine without learning to operate a new type of pump device. In one embodiment, the pump device 100 may be used in combination with the first controller device 200 so as to deliver a medicine 231 for the treatment of Type 2 Diabetes. Examples of such medicines 231 include Exenatide, which is commercially available under the name BYETTA™, or others in a class of medicines for Type 2 Diabetes called incretin mimetics. These medicines may improve control of Type 2 Diabetes by aiding the user's pancreas produce an appropriate amount of insulin. As described in more detail below in connection with
If the user's Diabetes progresses over time to become Type 1 Diabetes, the user may continue to use the same type of pump device 100 but with a different controller device 300 (e.g., a controller device for use in the infusion of insulin or other medicines to treat Type 1 Diabetes). Thus, the user is not required to obtain and learn about a new type of pump device 100. Instead, the user may conveniently attach the same type of pump device 100 (this time including a cartridge 330 with insulin 331) to a second controller device 300. As described in more detail below in connection with
Moreover, such embodiments of the infusion pump system 20 may provide manufacturing benefits. For example, the manufacturer may not be required to manufacture a different type of pump device 100 for each of the different types of controllers. Instead, the pump device 100 can be mass produced in high quantities for use in conjunction with any one of a plurality of controller devices (e.g., controller devices 200 and 300 in this embodiment).
Optionally, the first controller device 200 may include an indicia 225 that identifies the particular type of medicine cartridge 230 or medicine 231 with which it is to be employed. The medicine cartridge 230 may include a similar indicia 235. As such, the user can verify that the appropriate type of medicine 231 is received in the pump device 100 for controlled dispensation by the controller device 200. For example, the indicia 225 may include a label, marking, etching, or the like disposed on the controller housing structure 210 that indicates a particular name, code, or other identifier corresponding to a particular medicine 231 (e.g., “EXENATIDE” or “BYETTA” or another identifier). The indicia 235 disposed on the medicine cartridge 230 may include a similar label, marking, etching, or the like disposed on an outer surface of the cartridge 230 so as to indicate a particular name, code, or other identifier corresponding to the particular medicine 231. The second controller device 300 may also include an indicia 325 that identifies the particular type of medicine cartridge 330 or medicine 331 with which it is to be employed (e.g., “INSULIN” or another identifier). The indicia 325 may match a corresponding indicia 335 arranged on the medicine cartridge 330. Thus, a person or machine will be able to interpret the indicia 235 on the first cartridge 230 and the indicia 225 on the first controller device 220 to know that the first cartridge 230 is used in conjunction with the first controller device 200. Similarly, a person or machine will be able to interpret the indicia 335 on the second cartridge 230 and the indicia 325 on the second controller device 320 to know that the second cartridge 330 is used in conjunction with the second controller device 300.
Referring to
Referring to
Referring now to
One or both of the detachable shell 112 and the frame portion 113 can be molded from polymer material, such as Polycarbonate, Acrylonitrile Butadiene Styrene, or Acrylic. In this embodiment, the detachable shell portion 112 comprises a generally opaque, moldable material so that the drive system 105 and other components of the pump device are concealed from view. The frame portion 113 may include a cylindrical receiver 114 that defines the space 116 to receive the medicine cartridge 120 (
The receiver 114 may also include a connector to mate with the cap member 115. In this embodiment, the connector comprises an external thread pattern formed on the receiver 113 that mates with an internal thread pattern of the cap member 115. Accordingly, the cap member 115 can be secured to the frame portion 113 after the medicine cartridge 120 (
Still referring to
In this embodiment, the first battery 145 can be maintained in a storage mode and then switched to an activation mode when the pump device 100 used to dispense medicine. The storage mode can provide a long shelf life of storage life for the first battery 145. For example, when in storage mode, the first battery may retain a substantial portion of its charge for a period of more than six months, more than one year, or more than two years. As shown in
As shown in
Referring to
The controller device 200 can also include one or more electrical contacts 249 that provide electrical communication to a controller circuit 240. In this embodiment, the electrical contacts 249 are arranged on the controller housing structure 210 so as to align with the electrical contacts 149a (or the electrical contact device 149b) of the pump device 100 (refer, for example, to
Still referring to
The second battery 245 may include a high current output device that is capable discharging a brief current burst to power the drive system 105 of the pump device 100. Accordingly, the second battery 245 can be charged over a period of time by the first battery 145 and then intermittently deliver high-current bursts to the drive system 105 over a brief moment of time. For example, the second battery 245 may comprise a lithium polymer battery. The lithium polymer battery disposed in the controller device 200 may have an initial current output that is greater than the zinc-air cell battery disposed in the pump device 100, but zinc-air cell battery may have an energy density that is greater than the lithium polymer battery (e.g., the lithium polymer battery disposed in the controller device 200 may have a volumetric energy density of less than about 600 Wh/L). In addition, the lithium polymer battery is rechargeable, which permits the zinc-air battery disposed in the pump device 100 to provide electrical energy to the lithium polymer battery 245 for purposes of recharging. One exemplary lithium polymer battery is available from Sanyo Corporation of Japan, which provides a initial current output of about greater than 80 mA (about 90 mA to about 110 mA, and about 100 mA in this embodiment) and a maximum potential voltage of about 4.0V to and 4.4V (about 4.2 V in this embodiment). In other embodiments, it should be understood that the second battery 245 may comprise a capacitor device capable of recharging over time and intermittently discharging a current burst to activate the drive system 105.
Because the controller device 200 can be reusable with a number of pump devices 100 (e.g., attach a new pump device 100 after the previous pump device 100 is expended and disposed), the second battery 245 in the controller device can be recharged over a period of time each time a new pump device 100 is connected thereto. Such a configuration can be advantageous in those embodiments in which the pump device 100 is configured to be a disposable, one-time-use device that attaches to a reusable controller device 200. For example, in those embodiments, the “disposable” pump devices 100 recharge the second battery 245 in the “reusable” controller device 200, thereby reducing or possibly eliminating the need for separate recharging of the controller device 200 via a power cord plugged into a wall outlet.
The controller circuit 240 of the control device 200 includes a microcontroller device 246 that coordinates the electrical communication to and from the controller device 200. At least a portion of the controller circuit 240 can be embodied on a printed circuit board (or a flexible circuit substrate). The second battery 245 and the microcontroller 246 can be mounted to such a printed circuit board (or connect to such a flexible circuit substrate). Electrical connections from the electrical contacts 249 and the user interface 220 (
As shown in
Referring to
Referring to
Referring to
As shown in
The rotational motor 130 may comprise an electrically power actuator having a rotatable output shaft 132. In this embodiment, the rotational motor 130 can receive signals that cause the output shaft to rotate in a first rotational direction or in a second, opposite rotational direction. One example of a suitable rotational motor 130 is a coreless DC motor supplied by Jinlong Machinery of China. As previously described, the operation of the rotational motor 130 can be controlled by a controller device (e.g., removable controller device 200 or 300 as described in connection with
The string member 135 may be coupled to the rotational motor 130 so that actuation by the motor 130 causes the string member 135 to act upon the ratchet mechanism 150. One or more full rotations of the motor 130 can be translated into a tension force in the string member 135 that is applied to a pawl member 152, which (in this embodiment) is pivoted to a reset position by the tension force from the string member 135. As such, the string member 135 is coupled between the rotational motor 130 and the ratchet mechanism 150 so as to provide a reliable and consistent adjustment of the ratchet mechanism. In this embodiment, the string member 135 is coupled to the motor shaft 132 using a mechanical connector 133.
Still referring to
It should be understood that the drive system 105 can employ one or more sensors to indicate when the pawl member 152 has reach the reset position or the forward position. For example, these sensors can be optical, magnetic, or contact type sensors. The sensors may be capable of transmitting signals that indicate when the location of the pin structure 138 or the pawl member 152 is detected. Such sensor signals may be transmitted to the first circuit 140, to the controller device 200 or 300, or a combination thereof.
Still referring to
Accordingly, in some embodiments, the piston rod 170 may undergo only forward or positive displacement as a result of drive system 105. For example, the drive system 105 substantially hinders the piston rod 170 from retracting or “backing up” in response to fluid pressure in the medicine cartridge 120 or other reversal forces. In such circumstances, the flexible piston rod 170 can be retracted only upon disassembly of the pump device 100 (e.g., to disengage the gears or the ratchet mechanism). In those embodiments in which the pump device 100 is intended to be disposable, the non-retractable piston rod configuration (due to the drive system 105) may facilitate a “one time use” disposable pump device, thereby reducing the likelihood of failure due to non-intended repeated use of the disposable pump device.
The flexible piston rod 170 comprises a plurality of segments 172 serially connected by hinge portions so that the flexible piston rod 170 is adjustable from a curved shape to a noncurved shape. As previously described, the plurality of segments 172 and the interconnecting hinge portions can be integrally formed in one piece from a moldable material, including one or more polymer materials such as Nylon or POM. In this embodiment, the plurality of segments 172 comprise generally cylindrical segments that each include an exterior thread pattern along at least one cylindrical surface portion. The flexible piston rod 170 can include an anti-rotation structure that hinders the piston rod 170 from rotating with drive wheel 160 (thereby allowing the rotation of the drive wheel 160 to translate into a longitudinal motion of the piston rod 170). For example, in this embodiment, the flexible piston 170 includes a longitudinal channel 173 extending through each of the segments 172. The longitudinal channel 173 can engage a complementary protrusion on the frame portion 114 proximate the drive wheel 160 so that the flexible piston rod 170 is hindered from rotating when the drive wheel 160 turns relative to the frame portion 114. Accordingly, the longitudinal channel in each segment 172 aligns to form a keyway that receives a mating key (e.g., a protrusion) on the frame portion 114. In other embodiments, the anti-rotation structure may include a plurality of longitudinal channels 173 (with each channel capable of engaging an associated protrusion that acts as a key to hinder rotation while permitting longitudinal motion), one or more flat surfaces along each segment 172 (with the flat surface slideably engaging a complementary flat surface on the frame portion 114), or the like. A plunger connector 178 may be coupled to the leading end of the flexible piston rod 170 so as to abut against or connect with the plunger 121 in the plunger chamber 126 of the fluid cartridge 120. Previously incorporated U.S. Provisional Application Ser. No. 60/720,405 also describes a number of configurations for the flexible piston rod 170 in addition to the configuration illustrated in
Referring now to
Referring to
Referring to
Referring to
It should be understood, that in other embodiments, the incremental motion cycle may begin with the pawl member 152 starting at the forward position (refer to
The string member 135 may comprise braided filaments that are capable of enduring repeated twisting sequences of the string member 135. For example, the braided filaments may comprise one or more polymer materials, such as PET (e.g., DTex Dyneema material available from Honeywell, Inc.). Such braided filament string members are capable of enduring the torsion and frictional forces associated with undergoing thousands of cycles of twisting as described above in connection with
Referring now to
As shown in
Accordingly, in one incremental motion cycle, the pawl member 452 may start at the reset position with the string member 435 wound around the spindle device 434. In response to the controller device 200 or 300 (
In other embodiments, the incremental motion cycle may begin with the pawl member 452 starting at the forward position. In such circumstances, the rotational motor 430 would rotate in a first rotational direction to wind the string member 435 around the spindle device 434 until the pawl member 452 is moved to the reset position (as shown in
It should be understood that the drive system 405 can be contained in the housing structure 110 of the pump device 100 in a compact manner so that the pump device 100 is portable, wearable, concealable, or a combination thereof. Similar to previously described embodiments, the pump device 100 can be part of an infusion pump system 10 or 20 in which the pump device 100 communicates with a controller device, including but not limited to the removable controller device 200 or 300 described in connection with
A number of embodiments of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention. Accordingly, other embodiments are within the scope of the following claims.
This application is a continuation of U.S. patent application Ser. No. 13/161,292 filed Jun. 15, 2011, which is issued as U.S. Pat. No. 8,696,633, which is a continuation of U.S. patent application Ser. No. 11/924,203 filed on Oct. 25, 2007 by Mark Estes et al., which is issued as U.S. Pat. No. 7,981,084, which is a division of U.S. patent application Ser. No. 11/522,603 filed on Sep. 18, 2006 by Mark Estes et al., which is issued as U.S. Pat. No. 7,794,427, which claims priority to: (1) U.S. Provisional Application Ser. No. 60/720,411 filed on Sep. 26, 2005 by Mernoe et al. and entitled “Precision Drive Mechanism,” (2) U.S. Provisional Application Ser. No. 60/720,405 filed on Sep. 26, 2005 by Mernoe et al. and entitled “Flexible Pushrod Mechanism,” and (3) U.S. Provisional Application Ser. No. 60/721,267 filed on Sep. 28, 2005 by Estes et al. and entitled “Infusion Pump with Removable Controller.” The contents of these earlier applications are fully incorporated by reference herein.
| Number | Name | Date | Kind |
|---|---|---|---|
| 2605765 | Kollsman | Aug 1952 | A |
| 3886938 | Szabo et al. | Jun 1975 | A |
| 3999504 | Kearse | Dec 1976 | A |
| 4077405 | Haerten et al. | Mar 1978 | A |
| 4231368 | Becker | Nov 1980 | A |
| 4265241 | Portner et al. | May 1981 | A |
| 4300554 | Hessberg et al. | Nov 1981 | A |
| 4313439 | Babb et al. | Feb 1982 | A |
| 4360019 | Portner et al. | Nov 1982 | A |
| 4373527 | Fischell | Feb 1983 | A |
| 4398908 | Siposs | Aug 1983 | A |
| 4435173 | Siposs et al. | Mar 1984 | A |
| 4443218 | DeCant, Jr. et al. | Apr 1984 | A |
| 4493704 | Beard et al. | Jan 1985 | A |
| 4498843 | Schnieder et al. | Feb 1985 | A |
| 4529401 | Leslie et al. | Jul 1985 | A |
| 4562751 | Nason et al. | Jan 1986 | A |
| 4619653 | Fischell | Oct 1986 | A |
| 4678408 | Nason et al. | Jul 1987 | A |
| 4850817 | Nason et al. | Jul 1989 | A |
| 4902278 | Maget et al. | Feb 1990 | A |
| 5045064 | Idriss | Sep 1991 | A |
| 5088981 | Howson et al. | Feb 1992 | A |
| 5097122 | Colman et al. | Mar 1992 | A |
| 5139484 | Hazon | Aug 1992 | A |
| 5190522 | Wojcicki et al. | Mar 1993 | A |
| 5209230 | Swedlow et al. | May 1993 | A |
| 5250027 | Lewis et al. | Oct 1993 | A |
| 5261882 | Sealfon et al. | Nov 1993 | A |
| 5314412 | Rex | May 1994 | A |
| 5335994 | Weynant Nee Girones | Aug 1994 | A |
| 5338157 | Blomquist | Aug 1994 | A |
| 5342180 | Daoud | Aug 1994 | A |
| 5395340 | Lee | Mar 1995 | A |
| 5411487 | Castagna | May 1995 | A |
| 5545143 | Fischell et al. | Aug 1996 | A |
| 5549575 | Giambattista et al. | Aug 1996 | A |
| 5551850 | Williamson et al. | Sep 1996 | A |
| 5569186 | Lord et al. | Oct 1996 | A |
| 5626566 | Petersen et al. | May 1997 | A |
| 5637095 | Nason et al. | Jun 1997 | A |
| 5665065 | Colman et al. | Sep 1997 | A |
| 5718562 | Lawless et al. | Feb 1998 | A |
| 5741216 | Hemmingsen et al. | Apr 1998 | A |
| 5764034 | Bowman et al. | Jun 1998 | A |
| 5772635 | Dastur et al. | Jun 1998 | A |
| 5816306 | Giacomel | Oct 1998 | A |
| 5852803 | Ashby, III et al. | Dec 1998 | A |
| 5919167 | Mulhauser | Jul 1999 | A |
| 5925018 | Ungerstedt | Jul 1999 | A |
| 5928201 | Poulsen et al. | Jul 1999 | A |
| 5947934 | Hansen et al. | Sep 1999 | A |
| 5951530 | Steengaard et al. | Sep 1999 | A |
| 5957889 | Poulsen et al. | Sep 1999 | A |
| 5984894 | Poulsen et al. | Nov 1999 | A |
| 5984897 | Petersen et al. | Nov 1999 | A |
| 5993983 | Rozon | Nov 1999 | A |
| 5997475 | Bortz | Dec 1999 | A |
| 6003736 | Ljunggren | Dec 1999 | A |
| 6010485 | Buch-Rasmussen et al. | Jan 2000 | A |
| 6033377 | Rasmussen et al. | Mar 2000 | A |
| 6045537 | Klitmose | Apr 2000 | A |
| 6074372 | Hansen | Jun 2000 | A |
| 6110149 | Klitgaard et al. | Aug 2000 | A |
| 6127061 | Shun et al. | Oct 2000 | A |
| 6156014 | Petersen et al. | Dec 2000 | A |
| 6171276 | Lippe et al. | Jan 2001 | B1 |
| 6231540 | Smedegaard | May 2001 | B1 |
| 6248067 | Causey, III et al. | Jun 2001 | B1 |
| 6248090 | Jensen et al. | Jun 2001 | B1 |
| 6248093 | Moberg | Jun 2001 | B1 |
| 6277098 | Klitmose et al. | Aug 2001 | B1 |
| 6302855 | Lav et al. | Oct 2001 | B1 |
| 6302869 | Klitgaard | Oct 2001 | B1 |
| 6375638 | Nason et al. | Apr 2002 | B2 |
| 6379339 | Klitgaard et al. | Apr 2002 | B1 |
| 6381496 | Meadows et al. | Apr 2002 | B1 |
| 6404098 | Kayama et al. | Jun 2002 | B1 |
| 6427088 | Bowman, IV et al. | Jul 2002 | B1 |
| 6461331 | Van Antwerp | Oct 2002 | B1 |
| 6474219 | Klitmose et al. | Nov 2002 | B2 |
| 6485461 | Mason et al. | Nov 2002 | B1 |
| 6491684 | Joshi et al. | Dec 2002 | B1 |
| 6508788 | Preuthun | Jan 2003 | B2 |
| 6524280 | Hansen et al. | Feb 2003 | B2 |
| 6533183 | Aasmul et al. | Mar 2003 | B2 |
| 6537251 | Klitmose | Mar 2003 | B2 |
| 6540672 | Simonsen et al. | Apr 2003 | B1 |
| 6544229 | Danby et al. | Apr 2003 | B1 |
| 6547764 | Larsen et al. | Apr 2003 | B2 |
| 6551276 | Mann et al. | Apr 2003 | B1 |
| 6554798 | Mann et al. | Apr 2003 | B1 |
| 6554800 | Nezhadian et al. | Apr 2003 | B1 |
| 6558320 | Causey, III et al. | May 2003 | B1 |
| 6558351 | Steil et al. | May 2003 | B1 |
| 6562001 | Lebel et al. | May 2003 | B2 |
| 6562011 | Buch-Rasmussen et al. | May 2003 | B1 |
| 6564105 | Starkweather et al. | May 2003 | B2 |
| 6569126 | Poulsen et al. | May 2003 | B1 |
| 6571128 | Lebel et al. | May 2003 | B2 |
| 6577899 | Lebel et al. | Jun 2003 | B2 |
| 6582404 | Klitgaard et al. | Jun 2003 | B1 |
| 6585644 | Lebel et al. | Jul 2003 | B2 |
| 6585699 | Ljunggreen et al. | Jul 2003 | B2 |
| 6605067 | Larsen | Aug 2003 | B1 |
| 6613019 | Munk | Sep 2003 | B2 |
| 6641533 | Causey, III et al. | Nov 2003 | B2 |
| 6648821 | Lebel et al. | Nov 2003 | B2 |
| 6650951 | Jones et al. | Nov 2003 | B1 |
| 6656158 | Mahoney et al. | Dec 2003 | B2 |
| 6656159 | Flaherty | Dec 2003 | B2 |
| 6659948 | Lebel et al. | Dec 2003 | B2 |
| 6659978 | Kasuga et al. | Dec 2003 | B1 |
| 6659980 | Moberg et al. | Dec 2003 | B2 |
| 6663602 | Møller | Dec 2003 | B2 |
| 6668196 | Villegas et al. | Dec 2003 | B1 |
| 6669669 | Flaherty et al. | Dec 2003 | B2 |
| 6687546 | Lebel et al. | Feb 2004 | B2 |
| 6690192 | Wing | Feb 2004 | B1 |
| 6691043 | Ribeiro, Jr. | Feb 2004 | B2 |
| 6692457 | Flaherty | Feb 2004 | B2 |
| 6692472 | Hansen et al. | Feb 2004 | B2 |
| 6694191 | Starkweather et al. | Feb 2004 | B2 |
| 6699218 | Flaherty et al. | Mar 2004 | B2 |
| 6702779 | Connelly et al. | Mar 2004 | B2 |
| 6715516 | Ohms et al. | Apr 2004 | B2 |
| 6716198 | Larsen | Apr 2004 | B2 |
| 6723072 | Flaherty et al. | Apr 2004 | B2 |
| 6733446 | Lebel et al. | May 2004 | B2 |
| 6736796 | Shekalim | May 2004 | B2 |
| 6740059 | Flaherty | May 2004 | B2 |
| 6740072 | Starkweather et al. | May 2004 | B2 |
| 6740075 | Lebel et al. | May 2004 | B2 |
| 6744350 | Blomquist | Jun 2004 | B2 |
| 6749587 | Flaherty | Jun 2004 | B2 |
| 6752787 | Causey, III et al. | Jun 2004 | B1 |
| 6758810 | Lebel et al. | Jul 2004 | B2 |
| 6768425 | Flaherty et al. | Jul 2004 | B2 |
| 6780156 | Haueter et al. | Aug 2004 | B2 |
| 6786246 | Ohms et al. | Sep 2004 | B2 |
| 6786890 | Preuthun et al. | Sep 2004 | B2 |
| 6796970 | Klitmose et al. | Sep 2004 | B1 |
| 6799149 | Hartlaub | Sep 2004 | B2 |
| 6809653 | Mann et al. | Oct 2004 | B1 |
| 6810290 | Lebel et al. | Oct 2004 | B2 |
| 6811533 | Lebel et al. | Nov 2004 | B2 |
| 6811534 | Bowman, IV et al. | Nov 2004 | B2 |
| 6813519 | Lebel et al. | Nov 2004 | B2 |
| 6827702 | Lebel et al. | Dec 2004 | B2 |
| 6830558 | Flaherty et al. | Dec 2004 | B2 |
| 6852104 | Blomquist | Feb 2005 | B2 |
| 6854620 | Ramey | Feb 2005 | B2 |
| 6854653 | Eilersen | Feb 2005 | B2 |
| 6855129 | Jensen et al. | Feb 2005 | B2 |
| 6872200 | Mann et al. | Mar 2005 | B2 |
| 6873268 | Lebel et al. | Mar 2005 | B2 |
| 6878132 | Kipfer | Apr 2005 | B2 |
| 6893415 | Madsen et al. | May 2005 | B2 |
| 6899695 | Herrera | May 2005 | B2 |
| 6899699 | Enggaard | May 2005 | B2 |
| 6922590 | Whitehurst | Jul 2005 | B1 |
| 6936006 | Sabra | Aug 2005 | B2 |
| 6936029 | Mann et al. | Aug 2005 | B2 |
| 6945961 | Miller et al. | Sep 2005 | B2 |
| 6948918 | Hansen | Sep 2005 | B2 |
| 6950708 | Bowman IV et al. | Sep 2005 | B2 |
| 6960192 | Flaherty et al. | Nov 2005 | B1 |
| 6974437 | Lebel | Dec 2005 | B2 |
| 6979326 | Mann et al. | Dec 2005 | B2 |
| 6997911 | Klitmose | Feb 2006 | B2 |
| 6997920 | Mann et al. | Feb 2006 | B2 |
| 7005078 | Van Lintel et al. | Feb 2006 | B2 |
| 7008399 | Larson et al. | Mar 2006 | B2 |
| 7014625 | Bengtsson | Mar 2006 | B2 |
| 7018360 | Flaherty et al. | Mar 2006 | B2 |
| 7025743 | Mann | Apr 2006 | B2 |
| 7029455 | Flaherty | Apr 2006 | B2 |
| 7033338 | Vilks | Apr 2006 | B2 |
| 7052251 | Nason | May 2006 | B2 |
| 7054836 | Christensen et al. | May 2006 | B2 |
| 7083593 | Stultz | Aug 2006 | B2 |
| 7104972 | Møller et al. | Sep 2006 | B2 |
| 7128727 | Flaherty et al. | Oct 2006 | B2 |
| 7133329 | Skyggebjerg et al. | Nov 2006 | B2 |
| 7192414 | Stultz | Mar 2007 | B2 |
| 7198603 | Penner | Apr 2007 | B2 |
| 7232423 | Mernoe et al. | Jun 2007 | B2 |
| 7699833 | Moberg | Apr 2010 | B2 |
| 7935104 | Yodfat | May 2011 | B2 |
| 20010023637 | Klitmose et al. | Sep 2001 | A1 |
| 20010041869 | Causey, III et al. | Nov 2001 | A1 |
| 20010056262 | Cabiri | Dec 2001 | A1 |
| 20020004651 | Ljunggreen et al. | Jan 2002 | A1 |
| 20020040208 | Flaherty et al. | Apr 2002 | A1 |
| 20020091358 | Klitmose | Jul 2002 | A1 |
| 20020126036 | Flaherty et al. | Sep 2002 | A1 |
| 20020169439 | Flaherty | Nov 2002 | A1 |
| 20030055380 | Flaherty | Mar 2003 | A1 |
| 20030065308 | Lebel et al. | Apr 2003 | A1 |
| 20030088238 | Poulsen | May 2003 | A1 |
| 20030163088 | Blomquist | Aug 2003 | A1 |
| 20030163089 | Bynum | Aug 2003 | A1 |
| 20030176797 | Anzellini | Sep 2003 | A1 |
| 20030199825 | Flaherty | Oct 2003 | A1 |
| 20030216683 | Shekalim | Nov 2003 | A1 |
| 20040010207 | Flaherty et al. | Jan 2004 | A1 |
| 20040019325 | Shekalim | Jan 2004 | A1 |
| 20040030296 | Langley | Feb 2004 | A1 |
| 20040064088 | Gorman et al. | Apr 2004 | A1 |
| 20040064096 | Flaherty et al. | Apr 2004 | A1 |
| 20040078028 | Flaherty et al. | Apr 2004 | A1 |
| 20040087894 | Flaherty | May 2004 | A1 |
| 20040092865 | Flaherty et al. | May 2004 | A1 |
| 20040092878 | Flaherty | May 2004 | A1 |
| 20040116866 | Gorman et al. | Jun 2004 | A1 |
| 20040127844 | Flaherty | Jul 2004 | A1 |
| 20040153032 | Garribotto et al. | Aug 2004 | A1 |
| 20040171983 | Sparks et al. | Sep 2004 | A1 |
| 20040176727 | Shekalim | Sep 2004 | A1 |
| 20040204673 | Flaherty | Oct 2004 | A1 |
| 20040220551 | Flaherty et al. | Nov 2004 | A1 |
| 20040235446 | Flaherty et al. | Nov 2004 | A1 |
| 20040260233 | Garibotto et al. | Dec 2004 | A1 |
| 20050021005 | Flaherty et al. | Jan 2005 | A1 |
| 20050022274 | Campbell et al. | Jan 2005 | A1 |
| 20050065760 | Murtfeldt et al. | Mar 2005 | A1 |
| 20050090808 | Malave et al. | Apr 2005 | A1 |
| 20050095063 | Fathallah | May 2005 | A1 |
| 20050124866 | Elaz et al. | Jun 2005 | A1 |
| 20050160858 | Mernoe | Jul 2005 | A1 |
| 20050171512 | Flaherty | Aug 2005 | A1 |
| 20050182366 | Vogt et al. | Aug 2005 | A1 |
| 20050192561 | Mernoe | Sep 2005 | A1 |
| 20050203461 | Flaherty et al. | Sep 2005 | A1 |
| 20050215982 | Malave et al. | Sep 2005 | A1 |
| 20050222645 | Malave et al. | Oct 2005 | A1 |
| 20050238507 | DiIanni et al. | Oct 2005 | A1 |
| 20050245878 | Mernoe et al. | Nov 2005 | A1 |
| 20050251097 | Mernoe | Nov 2005 | A1 |
| 20050267402 | Stewart et al. | Dec 2005 | A1 |
| 20050273059 | Mernoe et al. | Dec 2005 | A1 |
| 20060041229 | Garibotto et al. | Feb 2006 | A1 |
| 20060069382 | Pedersen | Mar 2006 | A1 |
| 20060074381 | Malave et al. | Apr 2006 | A1 |
| 20060095014 | Ethelfeld | May 2006 | A1 |
| 20060135913 | Ethelfeld | Jun 2006 | A1 |
| 20060142698 | Ethelfeld | Jun 2006 | A1 |
| 20060178633 | Garibotto et al. | Aug 2006 | A1 |
| 20060184119 | Remde et al. | Aug 2006 | A1 |
| 20060200073 | Radmer et al. | Sep 2006 | A1 |
| 20060206054 | Shekalim | Sep 2006 | A1 |
| 20060247581 | Pedersen et al. | Nov 2006 | A1 |
| 20070073228 | Mernoe et al. | Mar 2007 | A1 |
| 20070073236 | Mernoe et al. | Mar 2007 | A1 |
| 20070088271 | Richards | Apr 2007 | A1 |
| 20070093750 | Jan et al. | Apr 2007 | A1 |
| 20070124002 | Estes et al. | May 2007 | A1 |
| 20070156092 | Estes et al. | Jul 2007 | A1 |
| 20070167905 | Estes et al. | Jul 2007 | A1 |
| 20070167912 | Causey et al. | Jul 2007 | A1 |
| 20080208627 | Skyggebjerg | Aug 2008 | A1 |
| Number | Date | Country |
|---|---|---|
| 2543545 | May 2005 | CA |
| 196 27 619 | Jan 1998 | DE |
| 19713082 | Oct 1998 | DE |
| 199 16 876 | Nov 2000 | DE |
| 102 36 669 | Feb 2004 | DE |
| 0 062 974 | Oct 1982 | EP |
| 0275213 | Jul 1988 | EP |
| 0 496 141 | Jul 1992 | EP |
| 0 612 004 | Aug 1994 | EP |
| 0 580 723 | Oct 1995 | EP |
| 0 275 213 | Jul 1998 | EP |
| 1 045 146 | Oct 2000 | EP |
| 1 136 698 | Sep 2001 | EP |
| 1 177 802 | Feb 2002 | EP |
| 0 721 358 | May 2002 | EP |
| 1 495 775 | Jan 2005 | EP |
| 1 527 792 | May 2005 | EP |
| 1 754 498 | Feb 2007 | EP |
| 1 818 664 | Aug 2007 | EP |
| 2 585 252 | Jan 1987 | FR |
| 747 701 | Apr 1956 | GB |
| 2 218 831 | Nov 1989 | GB |
| WO 9015928 | Dec 1990 | WO |
| WO 9721457 | Jun 1997 | WO |
| WO9804301 | Feb 1998 | WO |
| WO 9811927 | Mar 1998 | WO |
| WO 9857683 | Dec 1998 | WO |
| WO 9921596 | May 1999 | WO |
| WO 9939118 | Aug 1999 | WO |
| WO 9948546 | Sep 1999 | WO |
| WO 0172360 | Oct 2001 | WO |
| WO 0191822 | Dec 2001 | WO |
| WO 0191833 | Dec 2001 | WO |
| WO 0240083 | May 2002 | WO |
| WO 02057627 | Jul 2002 | WO |
| WO02068015 | Sep 2002 | WO |
| WO02084336 | Oct 2002 | WO |
| WO 02100469 | Dec 2002 | WO |
| WO03026726 | Apr 2003 | WO |
| WO 03103763 | Dec 2003 | WO |
| WO 2004056412 | Jul 2004 | WO |
| WO 2004110526 | Dec 2004 | WO |
| WO 2005002652 | Jan 2005 | WO |
| WO 2005039673 | May 2005 | WO |
| WO 2005072794 | Aug 2005 | WO |
| WO 2005072795 | Aug 2005 | WO |
| WO2006067217 | Jun 2006 | WO |
| WO2006097453 | Sep 2006 | WO |
| WO 2006105792 | Oct 2006 | WO |
| WO 2006105793 | Oct 2006 | WO |
| WO 2006105794 | Oct 2006 | WO |
| WO2007141786 | Dec 2007 | WO |
| Entry |
|---|
| Patent Translate: Translation of DE 19713082 A1, Jan. 5, 2016. |
| Medtronic News Release, “Medtronic Receives FDA Approval for World's First Insulin Pump with Real-time Continuous Glucose Monitoring,” Apr. 13, 2006, 3 pages. |
| Debiotech News Release, “Debiotech reveals its new miniaturized Disposable Insulin Nanopump™ for Diabetes therapy,” available at http://www.debiotech.com/news/nw—159.html Apr. 24, 2006, 3 pages. |
| Patent Abstracts of Japan, vol. 1999, No. 04, and JP 11 010036 , Apr. 30, 1999 and Jan. 19, 1999, Toray Ind. Inc. |
| Accu-Chek Spirit, “Pump Therapy Made for You,” Roche, 2006, 6 pages. |
| Xilas Temp Touch, “The latest in high-tech and convenient devices,” DOCNews, vol. 2, No. 7, Jul. 1, 2005, http://docnews.diabetesjournals.org/cgi/content/full/2/7/13, 3 pages. |
| The Medtronic Diabetes Connection, 2006, 6 pages. |
| OmniPod Insulin Management System-Investor Relations—Press Release, Feb. 1, 2005, http://investors.insulet.com/phoenix.zhtml?c=209336&p=irol-newsArticle&ID=988708&highlight= 1 page. |
| OmniPod Quick Start Guide, 2007, 2 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20140276431 A1 | Sep 2014 | US |
| Number | Date | Country | |
|---|---|---|---|
| 60721267 | Sep 2005 | US | |
| 60720405 | Sep 2005 | US | |
| 60720411 | Sep 2005 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 11522603 | Sep 2006 | US |
| Child | 11924203 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 13161292 | Jun 2011 | US |
| Child | 14208490 | US | |
| Parent | 11924203 | Oct 2007 | US |
| Child | 13161292 | US |
